Gallotannins and ellagitannins as regulators of cytokine release
申请人:The Penn State Research Foundation
公开号:US07288273B1
公开(公告)日:2007-10-30
A means and method for increasing or inhibiting the secretion of cytokines using gallotannins and ellagitannins is described. The preferred cytokine release inhibiting compounds are dimeric gallotannins having a linker molecule that misaligns the carbohydrate cores of the compounds. The preferred cytokine release promoting gallotannins and ellagitannins include a diaryl ether linker unit. In comparison to the more structurally complex ellagitannins, the compounds of this invention are structurally simpler, easier to synthesize, and more potent.
GALLOTANNINS AND ELLIGITANNINS AS REGULATORS OF CYTOKINE RELEASE
申请人:FELDMAN KENNETH S.
公开号:US20080070850A1
公开(公告)日:2008-03-20
A means and method for increasing or inhibiting the secretion of cytokines using gallotannins and ellagitannins is described. The preferred cytokine release inhibiting compounds are dimeric gallotannins having a linker molecule that misaligns the carbohydrate cores of the compounds. The preferred cytokine release promoting gallotannins and ellagitannins include a diaryl ether linker unit. In comparison to the more structurally complex ellagitannins, the compounds of this invention are structurally simpler, easier to synthesize, and more potent.
In vitro and in vivo inhibition of LPS-induced tumor necrosis factor-α production by dimeric gallotannin analogues
作者:Ken S Feldman、Sarah L Wilson、Michael D Lawlor、Charles H Lang、William J Scheuchenzuber
DOI:10.1016/s0968-0896(01)00251-6
日期:2002.1
Designed dimeric gallotannin analogues featuring two tetragalloylglucopyranose cores connected by various hydrocarbon linkers inhibit tumor necrosis factor-alpha secretion from lipopolysaccharide-stimulated human peripheral blood mononuclear cells by up to 53% (5-24 muM concentration range) compared to control. Comparable suppression of tumor necrosis factor-alpha levels (similar to 50% vs control) was observed in the plasma of rats co-treated with lipopolysaccharide and specific tannin analogues selected for their lack of interleukin 1-beta stimulating activity. (C) 2001 Elsevier Science Ltd. All rights reserved.
Nonsteroidal antiinflammatory agents. 1. 10,11-Dihydro-11-oxodibenz[b,f]oxepinacetic acids and related compounds